Active	Status	Sponsor type	Region	Phase	Filter
6 Active 7 Inactive 13 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

6 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Berry, Michael A
VIS Opti-K 002, NCT06702020: VIS Opti-K Vision Improvement for Presbyopes	Active, not recruiting	N/A	135	NA		VIS, Inc.	Presbyopia Correction	03/25	07/25
AMD, NCT04268836: Vision Improvement for Patients With Age-Related Macular Degeneration	Not yet recruiting	N/A	200	Canada	Optimal Acuity Clear-K® Low Vision Aid System treatment	Optimal Acuity Corporation, Bochner Eye Institute	Age-related Macular Degeneration	05/24	05/25
Opti-K Pres, NCT06597292: The VIS Opti-K Low Vision Aid Device Provides Vision Improvement.	Not yet recruiting	N/A	200	Canada, US	Vision improvement	VIS, Inc.	Hyperopia, Presbyopia	09/26	12/26
RCT, NCT05113927: Wide Field OCT + AI for Positive Margin Rates in Breast Conservation Surgery.	Completed	N/A	482	US	Selene	Perimeter Medical Imaging, Cancer Prevention Research Institute of Texas, Proxima Clinical Research, Biostatistical Consulting, Inc.	Breast Cancer	09/24	10/24
NCT04875234: Vision Improvement for Legally Blind Dry AMD Patients	Not yet recruiting	N/A	40	NA	Clear-K Low Vision Aid Treatment	Optimal Acuity Corporation	Dry Age-related Macular Degeneration, Vision Impairment and Blindness	07/25	12/26
PREDICT, NCT03448926: The Registry:	Recruiting	N/A	3000	US	Treatment Recommendation Surveys, 7-gene biosignature	PreludeDx, University of South Florida	DCIS	12/25	12/35